Obesity. Body mass index (BMI) pediatric, 85th percentile to less than 95th percentile for age
Conditions
Interventions
Intervention 1: Intervention group: This cohort will engage in conventional resistance training three times a week for a duration of 8 weeks. This training approach incorporates the use of barbells, d
Sponsors
The University of Isfahan
Eligibility
Sex/Gender
Male
Age
25 Years to 35 Years
Inclusion criteria
Inclusion criteria: The subjects are overweight/obese men who do not engage in regular exercise. Subjects should not have taken any supplements or their precursors for at least two months prior to the study. The subjects should not have any specific symptoms of disease such as: respiratory, cardiovascular or blood pressure, renal, or orthopedic diseases. Their body mass index is greater than 25 and less than 35 kg/m2.
Exclusion criteria
Exclusion criteria: Use of medications and sports supplements at the time of study entry. Having obvious physical and mental problems. Having any musculoskeletal diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MicroRNA-146a. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: The quantification of miRNA-146a is conducted utilizing specialized kits in conjunction with a RT-PCR apparatus.;MicroRNA-223. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: The quantification of miRNA-223 is conducted utilizing specialized kits in conjunction with a RT-PCR apparatus.;Testosterone hormone. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: It is measured using a testosterone ELISA kit and enzyme immunoassay.;Cortisol hormone. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: It is measured using a cortisol ELISA kit and enzyme immunoassay.;C- Reactive protein. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: It is measured using a C- Reactive protein ELISA kit and enzyme immunoassay.;Lipid profile. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: It is measured using lipid profile measurement kits and the photometric method.;Muscle strength. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: Muscular strength is measured using a dynamometer and exercise machines.;Cardiorespiratory Endurance. Timepoint: Measurements are taken prior to the commencement of the intervention and again 24 hours following its conclusion. Method of measurement: The participants' cardiorespiratory endurance is measured using a 20-meter | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVazgen Minasian
The university of Isfahan
Outcome results
None listed